{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:57:54Z","timestamp":1786993074724,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["118158"],"award-info":[{"award-number":["118158"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jns.2014.03.005","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T13:45:44Z","timestamp":1394718344000},"page":"103-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Clinical and biological changes under treatment with lithium carbonate and valproic acid in sporadic amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"340","author":[{"given":"Marie-Catherine","family":"Boll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Bayliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Vargas-Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Pe\u00f1aloza-Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireya","family":"Alcaraz-Zubeldia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2014.03.005_bb0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1474-4422(10)70068-5","article-title":"Efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Aggarwal","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2014.03.005_bb0010","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neuint.2008.01.009","article-title":"Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease","volume":"52","author":"Babu","year":"2008","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jns.2014.03.005_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"Controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2014.03.005_bb0020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/A:1022853531855","article-title":"Raised nitrate concentration and low SOD activity in the CSF of sporadic ALS patients","volume":"28","author":"Boll","year":"2003","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.jns.2014.03.005_bb0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00401-012-1058-5","article-title":"Unraveling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity","volume":"125","author":"Brockington","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jns.2014.03.005_bb0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"4","key":"10.1016\/j.jns.2014.03.005_bb0035","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.neuroscience.2009.11.034","article-title":"Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord","volume":"165","author":"Calder\u00f3","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2014.03.005_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2014.03.005_bb0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neuroscience.2006.09.064","article-title":"Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo","volume":"144","author":"Chi","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2014.03.005_bb0050","doi-asserted-by":"crossref","first-page":"52941e","DOI":"10.1371\/journal.pone.0052941","article-title":"Molecular imaging of microglial activation in amyotrophic lateral sclerosis","volume":"7","author":"Corcia","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.jns.2014.03.005_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2009.01.020","article-title":"Differential time-course of the increase of antioxidant thiol-defenses in the acute phase after spinal cord injury in rats","volume":"452","author":"D\u00edaz-Ruiz","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2014.03.005_bb0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuroscience.2008.06.040","article-title":"Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"155","author":"Feng","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2014.03.005_bb0065","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1073\/pnas.0708022105","article-title":"Lithium delays progression of amyotrophic lateral sclerosis","volume":"105","author":"Fornai","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jns.2014.03.005_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-4274(97)03869-1","article-title":"Cadmium levels in maternal, cord and newborn blood in Mexico City","volume":"91","author":"Galicia-Garc\u00eda","year":"1997","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jns.2014.03.005_bb0075","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00415-010-5609-1","article-title":"Progression in ALS is not linear but is curvilinear","volume":"257","author":"Gordon","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2014.03.005_bb0080","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jn\/104.5.580","article-title":"Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat","volume":"104","author":"Hafeman","year":"1974","journal-title":"J Nutr"},{"key":"10.1016\/j.jns.2014.03.005_bb0085","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0076-6879(94)33044-1","article-title":"Measurement of protein thiol groups and glutathione in plasma","volume":"233","author":"Hu","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jns.2014.03.005_bb0090","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.bbadis.2006.06.006","article-title":"Failure of protein quality control in amyotrophic lateral sclerosis","volume":"1762","author":"Kabashi","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jns.2014.03.005_bb0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","article-title":"Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS","volume":"66","author":"Kimura","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.03.005_bb0100","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1212\/WNL.47.6_Suppl_4.242S","article-title":"A confirmatory dose-ranging study of riluzole in ALS. ALS\/Riluzole Study Group-II","volume":"47","author":"Lacomblez","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.03.005_bb0105","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1523\/JNEUROSCI.5467-07.2008","article-title":"Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition","volume":"28","author":"Leng","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2014.03.005_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin-phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2014.03.005_bb0115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.0b013e31822dc7a5","article-title":"Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis Examining a more efficient trial design","volume":"77","author":"Miller","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.03.005_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jns.2007.09.038","article-title":"Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis","volume":"267","author":"Murata","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2014.03.005_bb0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.21620","article-title":"Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis","volume":"66","author":"Piepers","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2014.03.005_bb0130","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1289\/ehp.10578","article-title":"The effect of supplementation with omega-3 fatty acids on markers of oxidative stress in elderly exposed to PM2.5. Environ","volume":"116","author":"Romieu","year":"2008","journal-title":"Health Perspect"},{"key":"10.1016\/j.jns.2014.03.005_bb0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nrd2272","article-title":"Potential therapeutic applications of autophagy","volume":"6","author":"Rubinsztein","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jns.2014.03.005_bb0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/WNL.47.2.535","article-title":"Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis","volume":"47","author":"Sasaki","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2014.03.005_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/146608202760196011","article-title":"Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients","volume":"3","author":"Siciliano","year":"2002","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"2\u20133","key":"10.1016\/j.jns.2014.03.005_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/13547500500159001","article-title":"Creatinine versus specific gravity-adjusted urinary cadmium concentrations","volume":"10","author":"Suwazono","year":"2005","journal-title":"Biomarkers"},{"key":"10.1016\/j.jns.2014.03.005_bb0155","doi-asserted-by":"crossref","first-page":"15024","DOI":"10.1073\/pnas.1206362109","article-title":"Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2014.03.005_bb9000","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/mt.2013.108","article-title":"Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model","volume":"21","author":"Krakora","year":"2013","journal-title":"Mol. Ther."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14001488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14001488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T18:25:50Z","timestamp":1648578350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X14001488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0022510X14001488"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.03.005","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and biological changes under treatment with lithium carbonate and valproic acid in sporadic amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}